Jeong and collaborators [116] recently described the dysregulation of the iron homeostasis mechanism in the CNS in the G37R-SOD1 transgenic mice model of ALS, suggesting that iron chelation therapy might be useful for the treatment of ALS. Here, SOD1 is linked to amyotrophic lateral sclerosis.